Informations générales (source: ClinicalTrials.gov)
CT Evaluation of Cardiovascular Risk Markers in Obese Patients (RisqOScan)
Observational
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
novembre 2014
décembre 2017
29 juin 2024
Obesity is a chronic metabolic disorder : it leads to coronary heart disease and early
atherosclerosis.
Coronary artery calcium measured by CT is known as a robust predictor to predict risk for
cardiac events in symptomatic and asymptomatic individuals. Furthermore, recent studies
show that other CT risk factor exists, independent of calcium scoring, such as epicardial
fat, intrathoracic fat and visceral fat.
The aim of this prospective study is to evaluate these new cardiovascular risk markers in
obese patients, using standard dose CT and low dose CT with adaptative statistical
iterative reconstruction.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CHU Clermont-Ferrand - 63003 - Clermont-Ferrand - France | Patrick LACARIN | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- obesity >30 indicated non enhanced coroCT for calcium scoring.
- obesity >30 indicated non enhanced coroCT for calcium scoring.
- <18 ans
- low Framingham scoring
- pregnancy
- not providing informed consent
- history of cardiovascular disease.